CAMK2G and catecholaminergic polymorphic ventricular tachycardia: Moreover, experiments using CRISPR/CAS9 technology recently showed that phosphorylation at RyR2 CaMKII-specific site Serine-2814 is necessary to reveal CPVT phenotype [63].